Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Fully human anti-cd26 antibody and its application

A technology of CD26 and antibody, which is applied in the field of preparation and high-affinity fully human antibody to achieve the effect of inhibiting proliferation, invasion and metastasis

Active Publication Date: 2016-04-13
ZONHON BIOPHARMA INST
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the remaining few sequences of murine antibodies may still potentially trigger HAMA

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Fully human anti-cd26 antibody and its application
  • Fully human anti-cd26 antibody and its application
  • Fully human anti-cd26 antibody and its application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0061] The preparation of embodiment 1 CD26 extracellular region protein

[0062] The purpose of this study is to transfect eukaryotic cells with recombinant plasmids, G418 resistance screening to obtain stable transfected cell lines, secrete and express CD26 extracellular domain protein, and separate and purify CD26 extracellular domain protein by affinity chromatography.

[0063] The CD26 extracellular region gene is a synthetic gene selected from the "Extracellular" region of amino acids 29-766 in the sequence of Uniprot: P27487. The CD26 extracellular region gene is connected into the plasmid p3XFLAG-CMV9, and the enzyme cutting sites are HindIII and XbaI to construct the recombinant Plasmids (J. Sambrook. Molecular Cloning Experiment Guide. Third Edition. Science Press. 2002.P68).

[0064]Using LipofectamineLTX Reagent (purchased from Invitrogen) and following the instructions, the recombinant plasmid containing the CD26 extracellular region gene was transferred into HLF ...

Embodiment 2

[0066] Example 2 Isolation of Fully Human Anti-CD26 Single Chain Antibody

[0067] The single-chain antibody is obtained from a human single-chain antibody phage display library by solid-phase affinity screening of the CD26 extracellular region protein. The human single-chain antibody phage display library was constructed by Jiangsu Zhonghong Bioengineering Pharmaceutical Research Institute Co., Ltd. The phage display library containing the heavy chain and light chain variable regions of antibodies produced by human cells was constructed from human peripheral blood lymphocytes. The first round of amplification was carried out by using primers specific to the antibody variable region genes, and the second round of amplification was repeated. The variable regions of the light and chain chains were connected with a flexible linker peptide gene to form a single-chain antibody gene, and the single-chain antibody gene was cloned into the plasmid pHEN2 to transform Escherichia coli TG...

Embodiment 3

[0072] Example 3 Soluble expression and separation and purification of anti-CD26 single chain antibody

[0073] pHEN2 is a bifunctional phagemid vector with an amber stop codon (Amber) TAG between the expression detection tag (c-mytag) and the coat protein gene. If the phage is infected with an amber mutation (SupE) suppressor strain, such as TG1, the TAG codon is translated into glutamic acid, the sequence can be read through and translated, and the antibody fragment is fused to the coat protein p3 and expressed on the surface of the phage; when the phage is infected with a non-amber mutation suppressor For strains, such as HB2151, translation is terminated at TAG, and soluble antibody fragments can be obtained. The C-terminus of the antibody fragment has 6×Histag and c-myctag, which is convenient for purification, detection and identification. ZHB-2cF9 single-chain antibody is soluble expressed in the periplasmic space of Escherichia coli, purified by high-osmotic method to...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
molecular weightaaaaaaaaaa
Login to View More

Abstract

The invention provides a new high-affinity fully human antibody capable of specifically binding to CD26, a preparation method and application thereof, and belongs to the technical field of genetic engineering antibodies. CD26 is a ubiquitous multifunctional type II transmembrane glycoprotein, which has various biological functions and can interact with various proteins, such as ADA, CD45, FAP-alpha and so on. The present invention provides a human-derived antibody or fragment thereof, which specifically binds to human CD26, preferably specifically binds to the extracellular region of CD26, and the amino acid sequence of the antibody or fragment thereof comprises: SEQ? ID? NO: 2. SEQ? ID? NO: 3. SEQ? ID? NO: 4. SEQ? ID? NO: 6. SEQ? ID? NO: 7, SEQ? ID? NO: 8 A monoclonal antibody or fragment thereof or a conjugate of a fragment thereof in any region of the six complementarity-determining regions of a set of sequences, or an amino acid sequence obtained by amino acid substitution or modification. The anti-CD26 single-chain antibody obtained in the present invention has high specific binding to CD26, and can also obviously inhibit the proliferation, invasion and metastasis of tumor cells.

Description

technical field [0001] The invention belongs to the technical field of genetic engineering antibodies, and in particular relates to a new high-affinity fully human antibody capable of specifically binding to CD26, a preparation method and application thereof. Background technique [0002] CD26 is a ubiquitous multifunctional type II transmembrane glycoprotein with multiple biological functions and can also exist in plasma in a dissolved form. CD26 often exists in the form of homodimers, and its monomer contains 766 amino acids with a relative molecular mass of about 110kDa. Amino acid residues are divided into 5 parts from inside to outside: intracellular region (1-6), transmembrane region (7-28), highly glycosylated region (29-323), cysteine-rich region (324 ~551) and the C-terminal catalytic domain (552~766), the three-dimensional structure of CD26 molecule is closely related to its function. The C-terminal catalytic domain of CD26 exerts dipeptidyl peptidase IV (Dipepti...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07K16/28C12N15/13C12N15/63C12N1/15C12N1/19C12N1/21A61K39/395A61P35/00
CPCA61P35/00C07K16/2896C07K16/40C07K2317/21
Inventor 马永周雅琼高云霞黄粱敏徐春林陈晨王耀方
Owner ZONHON BIOPHARMA INST
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products